Brian T. Crum - 28 Feb 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Issuer symbol
LXRX
Transactions as of
28 Feb 2023
Net transactions value
-$44,565
Form type
4
Filing time
01 Mar 2023, 15:49:51 UTC
Previous filing
13 Feb 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +21,030 +21% 120,488 28 Feb 2023 Direct F1
transaction LXRX Common Stock Options Exercise +8,750 +7.3% 129,238 28 Feb 2023 Direct F1
transaction LXRX Common Stock Options Exercise +26,097 +20% 155,335 28 Feb 2023 Direct F1
transaction LXRX Common Stock Tax liability $44,565 -20,537 -13% $2.17 134,798 28 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -21,030 -100% 0 28 Feb 2023 Common Stock 21,030 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -8,750 -50% 8,750 28 Feb 2023 Common Stock 8,750 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -26,097 -33% 52,193 28 Feb 2023 Common Stock 26,097 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.